BG105273A - New use of taxoid derivatives - Google Patents

New use of taxoid derivatives

Info

Publication number
BG105273A
BG105273A BG105273A BG10527301A BG105273A BG 105273 A BG105273 A BG 105273A BG 105273 A BG105273 A BG 105273A BG 10527301 A BG10527301 A BG 10527301A BG 105273 A BG105273 A BG 105273A
Authority
BG
Bulgaria
Prior art keywords
new use
hydroxy
colon cancer
relates
present
Prior art date
Application number
BG105273A
Other languages
Bulgarian (bg)
English (en)
Inventor
Marie-Christine Bissery
Patricia Vrignaud
Simon Roberts
Clive Brealey
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP98115650A external-priority patent/EP0982028A1/fr
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of BG105273A publication Critical patent/BG105273A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BG105273A 1998-08-20 2001-02-20 New use of taxoid derivatives BG105273A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP98115650A EP0982028A1 (fr) 1998-08-20 1998-08-20 Nouvelle utilisation de dérivés de taxoides
US12384399P 1999-03-11 1999-03-11
FR9906292 1999-08-18

Publications (1)

Publication Number Publication Date
BG105273A true BG105273A (en) 2001-11-30

Family

ID=26149552

Family Applications (1)

Application Number Title Priority Date Filing Date
BG105273A BG105273A (en) 1998-08-20 2001-02-20 New use of taxoid derivatives

Country Status (15)

Country Link
EP (1) EP1105119A2 (fr)
JP (1) JP2002523364A (fr)
KR (1) KR20010079665A (fr)
CN (1) CN1313764A (fr)
AU (1) AU5742099A (fr)
BG (1) BG105273A (fr)
CA (1) CA2341191A1 (fr)
EE (1) EE200100082A (fr)
HU (1) HUP0104000A3 (fr)
IL (1) IL141231A0 (fr)
MX (1) MXPA01001721A (fr)
NO (1) NO20010655L (fr)
SK (1) SK2352001A3 (fr)
TR (1) TR200100575T2 (fr)
WO (1) WO2000010547A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2922107B1 (fr) * 2007-10-10 2010-02-26 Aventis Pharma Sa Nouvelles compositions a base de taxoides
WO2011051894A1 (fr) 2009-10-29 2011-05-05 Aventis Pharma S.A. Nouvelle utilisation antitumorale du cabazitaxel

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2697522B1 (fr) * 1992-10-30 1994-11-25 Rhone Poulenc Rorer Sa Procédé de préparation de dérivés du taxane.
MA23823A1 (fr) * 1995-03-27 1996-10-01 Aventis Pharma Sa Nouveaux taxoides, leur preparation et les compositions qui les contiennent
FR2732968B1 (fr) * 1995-04-14 1997-05-16 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
MXPA01001721A (es) 2005-06-03
CN1313764A (zh) 2001-09-19
TR200100575T2 (tr) 2001-07-23
KR20010079665A (ko) 2001-08-22
CA2341191A1 (fr) 2000-03-02
NO20010655D0 (no) 2001-02-07
IL141231A0 (en) 2002-03-10
WO2000010547A2 (fr) 2000-03-02
HUP0104000A3 (en) 2003-01-28
JP2002523364A (ja) 2002-07-30
AU5742099A (en) 2000-03-14
WO2000010547A3 (fr) 2000-06-29
HUP0104000A2 (hu) 2002-04-29
EE200100082A (et) 2002-06-17
EP1105119A2 (fr) 2001-06-13
SK2352001A3 (en) 2001-07-10
NO20010655L (no) 2001-02-07

Similar Documents

Publication Publication Date Title
HK1045311A1 (en) Triazole compounds with dopamine-d3-receptor affinity
DE69828436D1 (de) Radioaktive embolisierende zusammensetzungen
MX9706345A (es) Compuestos que contienen benzopiran y metodo para su uso.
EG24212A (en) Compositions of restricted cancer cells which produce cancer cell proliferation suppressive materials and uses thereof
BG103152A (en) Appoptosis-inducing adamantyl derivatives and their application as anticarcerogenic forms
WO2001052904A3 (fr) Compositions renfermant des oligonucleotides antisens diriges contre le vegf et methodes associees
BG102976A (en) Method for the preparation of drospyrenon (6 beta,7 beta: 15 beta,16 beta - dimethylene-3-oxo-17 alpha -pregn-4-ene-21,17-carbolacton, drsp)as well as 7 alpha-(3-hydroxy-1-propyl)-(6 beta,7 beta: 15 beta,16 beta -dirmethylene-5 beta-androstan-3 beta,5,17 beta -triol (zk 92836) and (6 beta,7 beta: 15 beta,16 beta - dimethylene-5 beta-hydroxy-3-oxo-17 alpha -androstan-21, 17-carbolacton (90965) as intermediate compounds of the method
DE69942827D1 (de) Verwendung der epothilons zur behandlung der krebs
BG106103A (en) Estrogen receptor-beta-ligands
ZA974512B (en) Process for extraction of proanthocyanadins from botanical material.
DE69803332D1 (de) Hartmolybdänlegierung, verschliessfeste Legierung und Verfahren zu ihrer Herstellung
AU2001233913A1 (en) Bcmp 84, a protein associated to breast cancer
CA2340921A1 (fr) Utilisation de taxanes pour traiter le cancer du cerveau
ZA9711580B (en) Process for the production of purified dimeric bone morphogenetic factors.
AU2162701A (en) Catalysts which are based on organic-inorganic hybrid materials containing noblemetals and titanium and which are used for selectively oxidizing hydrocarbons
DE69704833D1 (en) Derivate der thiazolidine-4-carbonsäure als cytoprotektive mittel
BG105273A (en) New use of taxoid derivatives
NZ512294A (en) Feed rolls with replaceable flute elements
AUPO684997A0 (en) Polyphenol oxidase genes from banana, tobacco & pineapple
EA200100250A1 (ru) Новое применение таксоидных производных
IL189502A0 (en) Methods and compositions for inhibiting neoplastic cell growth
PL331321A1 (en) Treatment pf psychotic disorders
GB2378135A (en) Compositions derived from modiolus modiolus and methods for making and using same
AU6091499A (en) Method for separating reduced sulphur compounds from concentrated odour gases ofa pulp mill
MY117925A (en) Compounds for the inhibition of farnesyl protein transferase.